Introduction:

In the last decade, the concept of "biomedicalization" has played a relevant role in Latin American Science, Technology, and Biomedicine (STS) studies amidst sociological and academic debates on the implications of biomedical interventions in the production of subjects and diseases. However, its relationship with sexuality has scarcely been evaluated.

Development:

This article aimed to analyze how sexual risk to avoid acquiring both human immunodeficiency virus through PrEP implementation and human papilloma virus through the preventive vaccine implementation in Mexico, Colombia, and Brazil has been thoroughly biomedicalized, from a sociological feminist perspective. First, the concept of biomedicalization and its theoretical uses in medical sociology and STS are briefly introduced. Then, few relevant texts are discussed that approach some aspects concerning the increase in biomedicalization of sexual risk within these biotechnologies in the three countries. Finally, we analyzed the advantages and challenges of introducing the concept of biomedicalization in the Latin American context and its relevance in terms of understanding sex-related relationships and differences.

Conclusions:

With the recent development of the biomedicine and transnational pharmaceutical industry, it is necessary to analyze the historical, social, and political implications of the biomedicalization of sexuality in the postcolonial contexts, such as those found in Latin America.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )